How Many Patients with Type 2 Diabetes Meet the Inclusion Criteria of the Cardiovascular Outcome Trials with SGLT2 Inhibitors? Estimations from a Population Database in a Mediterranean Area.
Silvia CanivellManel Mata-CasesBogdan VlachoMònica GratacòsJordi RealEsmeralda CastelblancoJosep FranchPublished in: Journal of diabetes research (2019)
The external validity of the analysed CVOTs is clearly limited when applying the same eligibility criteria to a T2D Mediterranean population.
Keyphrases